Status:
NOT_YET_RECRUITING
SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC
Lead Sponsor:
Korea University Guro Hospital
Conditions:
Robotics
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Single-POrt Robotic-assisted thoracic surgery versus single-port video-assisted Thoracic Surgery major pulmonary resection for patients with non-small cell lung cancer (SPORTS trial): a single-center,...
Detailed Description
Investigators initially began single-port robotic thoracic surgery using the SP robotic system for simple procedures, such as thymectomy and mediastinal mass excision. As their expertise grew, they ex...
Eligibility Criteria
Inclusion
- Candidate for anatomical pulmonary resection (segmentectomy or lobectomy) via minimally invasive thoracic surgery (RATS or VATS) for patient with non-small cell lung cancer or suspected malignant lesion.
- Age ≥ 18 years
- Patients who can comply with the requirements of the clinical trial and who, or their legal representatives, provide written consent before the start of the clinical trial
- Patients with the nationality of South Korea
- American Society of Anesthesiologists score 1-3.
- Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
Exclusion
- Patients who require surgery for accompanying other organ diseases
- Tumor invasion into the chest wall, diaphragm, another lobe or diaphragm
- Patients who are considered unsuitable based on the researcher's judgment
- Patients with cognitive impairments who are unable to understand the instructions and informed consent of this study
- Patients who specifically desire a certain surgical method (robotic, thoracoscopic, open thoracotomy)
- Patients who previously undergone a thoracic surgical procedure in the hemithorax to be operated on
- Pathological results other than NSCLC (ex, benign nodules, metastatic lung cancer, SCLC)
- Patients who received neoadjuvant therapy.
- Candidate for pneumonectomy, bilobectomy, lobectomy plus segmentectomy, non-anatomic resection (ex, wedge resection).
- History of other cancers in the past 5 years.
Key Trial Info
Start Date :
January 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2031
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT06202690
Start Date
January 9 2024
End Date
June 30 2031
Last Update
January 11 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.